查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2081831

維生素D療法市場：全球市場預測（按產品類型、劑型、適應症、最終用戶和分銷管道分類），2026-2032年

Vitamin D Therapy Market by Product Type, Dosage Form, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，維生素 D 療法市場將成長至 96.8 億美元，複合年成長率為 13.15%。

主要市場統計數據
基準年 2025 40.7億美元
預計年份：2026年 45.8億美元
預測年份 2032 96.8億美元
複合年成長率 (%) 13.15%

維生素D療法市場簡介

維生素D療法正從狹義上維持骨骼健康的干預措施，轉向更廣泛、更具循證依據的範疇，涵蓋處方藥（如骨化三醇及其類似物）、膽鈣化醇和麥角鈣化醇補充劑、強化食品，以及針對臨床確診維生素D缺乏症的規範化替代療法。這項需求得到了既定生理學研究的支持。維生素D對於維持鈣磷穩態、骨骼鈣化以及預防佝僂病和骨軟化症至關重要，而某些特定人群，例如老年人、吸收不良者、慢性腎臟病病患者、肥胖者、膚色較深者、日照不足者以及居住在護理機構的人群，更容易出現維生素D病患小組。

維生素D療法的格局發生了變革性變化

維生素D治療的格局正在重塑，從統一的補充劑攝取建議轉向基於風險的標靶治療。臨床機構越來越注重治療已確診維生素D缺乏症或高風險族群，而不是空泛地宣稱其具有廣泛的疾病預防作用。這推動了市場對具有生物利用度數據、穩定性測試、第三方品質檢驗和透明劑量說明的產品的需求。

人工智慧對維生素D療法的累積影響

人工智慧 (AI) 透過增強需求預測、配方開發、患者細分和藥物安全監測，正在累積改善維生素 D 療法。 AI 模型能夠結合處方趨勢、季節性紫外線照射、人口統計數據、保險理賠數據以及 25-羥基維生素 D 檢測模式，識別最有可能需要補充維生素 D 的地區和人群。對於生產商而言，這有助於他們更聰明地進行庫存規劃和分銷，因為該類別受季節性、營養指導和公共衛生訊息的影響。

關於維生素D療法的關鍵區域見解

儘管亞太地區許多國家陽光充足，但由於城市生活方式、空氣污染、室內工作、穿著遮蓋皮膚的衣物、使用防曬油以及飲食中天然維生素D含量有限等因素，該地區普遍存在維生素D缺乏症，因此蘊藏著巨大的市場機會。中國、印度、日本、澳洲和韓國的政策環境各不相同，涵蓋了從擴大膳食補充劑零售和強化食品到滿足老齡化社會的需求以及引入臨床試驗等各個方面。北美仍然是維生素D治療市場最成熟的地區之一，膳食補充劑滲透率高，25-羥基維生素D檢測基礎設施完善，美國國立衛生研究院 (NIH) 和加拿大衛生署製定的明確每日建議攝取量也對消費者和專業人士的使用產生影響。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

東協市場正透過藥局主導的膳食補充劑使用、母嬰健康計劃以及中產階級日益成長的健康支出而不斷擴張，但各成員國在產品品質標準、食品添加劑使用規範和醫療保健服務可近性方面存在顯著差異。在海灣合作理事會（GCC）國家，臨床需求尤其突出，因為多個群體中已證實存在維生素D水平偏低的情況，因此，對醫生進行培訓、提供高品質的配方、制定符合當地文化的用藥依從性計劃以及開展實驗室檢測治療至關重要。歐盟強調膳食補充劑的安全性、攝取上限、標籤合規性和循證健康聲明，同時承認各國在強化食品和醫保報銷方面存在差異，從而構建了一個擴充性的維生素D治療環境，但同時也需要認真考慮合規性問題。

深入了解維生素D療法首選市場中的關鍵國家。

美國在消費者獲取管道、直銷健康通路、藥局分銷和臨床試驗方面處於主導地位。另一方面，加拿大受益於公共衛生指南、冬季相關的營養補充需求以及已建立的營養素基準值。預計墨西哥和巴西的零售市場將透過藥局和私人診所實現成長，這其中蘊藏著與骨骼健康、孕產婦保健、兒童營養以及不斷壯大的中產階級需求相關的機會。在歐洲，英國、德國、法國、義大利和西班牙的需求穩定，這得益於人口老化、骨質疏鬆症預防的優先地位以及基於指南的醫療保健。同時，俄羅斯寒冷的氣候、高緯度以及冬季有限的紫外線B照射量，推動了季節性營養補充劑的使用和針對性補充。

為維生素D療法領域的領導者提供的實用建議

業內供應商應優先考慮臨床可信度，明確區分維持性補充劑、缺乏症替代劑和處方類似物療法。包裝和專業教育材料應清楚標示劑量、配方、目標族群、使用期限、實驗室注意事項、禁忌症和安全限制。投資第三方檢測、污染物控制、穩定性數據、活性成分含量檢驗以及透明的採購管道，將有助於產品在競爭激烈的消費管道中脫穎而出。

調查方法

本執行摘要基於對權威公共衛生和臨床資訊來源的三角分析，包括國家營養攝取框架、監管指南、關於維生素D狀況的同行評審文獻以及關於維生素D缺乏症治療和安全性的既有檢驗。市場分析考慮了製劑類型、治療環境、分銷管道、患者風險群體、當地醫療保健基礎設施、營養強化政策以及檢測的可及性。

結論

鑑於維生素D缺乏症的臨床治療已得到證實，人群中持續存在的風險因素，以及老齡化社會對骨骼健康的日益關注，維生素D療法仍然是醫療保健和健康領域的一個重要分支。最具前景的商業性機會正從通用高劑量補充劑和未經證實的治療定位，轉向有針對性、循證且品質有保證的解決方案。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 維生素D療法市場：依產品類型分類

  • 營養強化食品
    • 飲料
    • 奶粉
  • 處方
  • 補充

第8章：維生素D療法市場：以劑型分類

  • 口服
    • 膠囊
    • 咀嚼片
    • 液體
    • 軟凝膠
    • 藥片
  • 腸外
  • 外用

第9章：維生素D療法市場：依適應症分類

  • 低血鈣
  • 骨質疏鬆症
  • 銀屑病
  • 疳

第10章：維生素D療法市場：以最終用戶分類

  • 診所
  • 家庭醫療保健
  • 醫院

第11章：維生素D療法市場：依分銷管道分類

  • 離線
  • 線上

第12章：維生素D療法市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：維生素D療法市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 維生素D療法市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Allergan plc
  • Amway Corporation
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bio-Techne Corporation
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • DSM Nutritional Products AG
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Herbalife Nutrition Ltd.
  • Lupin Limited
  • Merck & Co. Inc.
  • Nestle Health Science
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila
Product Code: MRR-4302AC721F94

The Vitamin D Therapy Market is projected to grow by USD 9.68 billion at a CAGR of 13.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.07 billion
Estimated Year [2026] USD 4.58 billion
Forecast Year [2032] USD 9.68 billion
CAGR (%) 13.15%

Vitamin D Therapy Market Introduction

Vitamin D therapy is moving from a narrowly defined bone-health intervention toward a broader, evidence-guided category spanning prescription calcitriol and analogs, cholecalciferol and ergocalciferol supplementation, fortified foods, and protocolized repletion for clinically confirmed deficiency. Demand is supported by established physiology: vitamin D is required for calcium and phosphate homeostasis, skeletal mineralization, and prevention of rickets and osteomalacia, while specific patient groups, including older adults, people with malabsorption, chronic kidney disease, obesity, darker skin pigmentation, limited sun exposure, and institutionalized populations, face higher deficiency risk.

For manufacturers and brand owners, the market opportunity is strongest where therapy is paired with credible testing, clear dosing, high-quality formulations, and compliance with national guidance. The U.S. National Institutes of Health lists recommended dietary allowances of 600 IU daily for adults through age 70 and 800 IU for adults over 70, with a tolerable upper intake level of 4,000 IU for most adults; these benchmarks continue to shape product labeling, clinician education, and safety positioning.

Transformative Shifts in the Vitamin D Therapy Landscape

The vitamin D therapy landscape is being reshaped by a shift from mass supplementation claims toward targeted, risk-based therapy. Clinical bodies increasingly emphasize treating confirmed deficiency and high-risk patients rather than promoting broad, unsupported disease-prevention claims. This creates a premium for products backed by bioavailability data, stability testing, third-party quality verification, and transparent dosing instructions.

Another transformative shift is the convergence of pharmaceutical-grade vitamin D analogs, consumer supplementation, and food fortification policy. Prescription forms remain essential for renal and endocrine indications, while over-the-counter products compete on format innovation such as softgels, sprays, gummies, liquids, tablets, and combination calcium-vitamin D products. Regulatory scrutiny over health claims and upper-limit safety is rising, making compliant evidence communication a core competitive advantage.

Cumulative Impact of Artificial Intelligence in Vitamin D Therapy

Artificial intelligence is cumulatively improving vitamin D therapy by strengthening demand planning, formulation development, patient segmentation, and pharmacovigilance. AI models can combine prescription trends, seasonal UV exposure, demographics, claims data, and 25-hydroxyvitamin D testing patterns to identify regions and populations most likely to require repletion therapy. For manufacturers, this supports smarter inventory planning and channel allocation in a category affected by seasonality, nutrition guidance, and public-health messaging.

AI also supports quality and safety. Machine-learning tools can monitor adverse-event databases, detect excessive-dose signals, analyze customer feedback for tolerability concerns, and optimize clinical trial recruitment for vitamin D analogs. The most durable value will come from responsible AI systems that maintain clinical guardrails, protect patient privacy, and avoid converting observational associations into unsupported therapeutic claims.

Key Regional Insights for Vitamin D Therapy

Asia-Pacific presents a high-volume opportunity because vitamin D insufficiency is widely reported despite abundant sunlight in many countries, driven by urban lifestyles, air pollution, indoor work, skin-covering clothing, sunscreen use, and dietary patterns with limited naturally occurring vitamin D. China, India, Japan, Australia, and South Korea each combine different policy settings, from supplement retail expansion and fortified foods to aging-population needs and clinical testing adoption. North America remains one of the most mature vitamin D therapy markets, with strong supplement penetration, established 25-hydroxyvitamin D testing infrastructure, and clear NIH and Health Canada reference intakes influencing consumer and professional use.

Latin America is expanding through pharmacy retail, private clinics, pediatric supplementation, and growing awareness of bone health, with Brazil and Mexico acting as important demand centers for accessible formulations. Europe is shaped by national fortification differences, aging demographics, latitude-related winter UVB limitations, and reimbursement rules that vary by country, making guideline alignment essential. The Middle East has substantial deficiency risk despite intense sunlight, largely due to indoor living, clothing practices, limited dietary intake, and high use of air-conditioned environments, supporting demand for physician-guided therapy. Africa shows uneven access: urban private markets are growing, but affordability, laboratory availability, nutrition-program integration, and supply-chain reliability remain critical determinants of adoption.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are expanding through pharmacy-led supplementation, maternal-child health initiatives, and rising middle-class wellness spending, although product quality standards, fortification practices, and healthcare access differ widely across member states. The GCC has a pronounced clinical need due to documented low vitamin D status across several populations, making physician education, premium formulations, culturally relevant adherence programs, and testing-linked therapy important. The European Union emphasizes supplement safety, upper intake limits, labeling compliance, and health-claim substantiation while allowing national differences in fortification and reimbursement, creating a compliance-sensitive but scalable vitamin D therapy environment.

BRICS countries represent large-volume potential, especially China, India, and Brazil, where population size, urbanization, dietary transition, and expanding diagnostics support demand for repletion and maintenance products. G7 markets are more mature and evidence-driven, rewarding brands that align with clinical guidelines, validated claims, traceable quality systems, and professional-channel education. NATO countries overlap significantly with North America and Europe, where military readiness, veteran health, institutional healthcare programs, and supplementation policies for personnel with limited sun exposure can support targeted vitamin D therapy for at-risk populations without overextending disease-prevention claims.

Key Country Insights for Priority Vitamin D Therapy Markets

The United States leads in consumer access, direct-to-consumer wellness channels, pharmacy distribution, and clinical testing, while Canada benefits from public-health guidance, winter-related supplementation needs, and established nutrient reference values. Mexico and Brazil offer retail growth through pharmacies and private clinics, with opportunities tied to bone health, maternal care, pediatric nutrition, and expanding middle-income demand. In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady demand supported by aging populations, osteoporosis prevention priorities, and guideline-based care, while Russia's colder climate, high latitude areas, and limited winter UVB exposure support seasonal supplementation and targeted repletion.

China and India are strategic vitamin D therapy markets because large populations, urban indoor living, air pollution, dietary limitations, and rising diagnostic awareness create substantial repletion demand. Japan and South Korea combine aging demographics with sophisticated healthcare systems, high expectations for product quality, and growing interest in preventive nutrition. Australia has strong public-health awareness but must balance supplementation with sun-exposure guidance and skin-cancer prevention, making evidence-based positioning, dose clarity, and clinician-aligned communication particularly important.

Actionable Recommendations for Vitamin D Therapy Leaders

Industry vendors should prioritize clinically credible positioning by separating maintenance supplementation, deficiency repletion, and prescription analog therapy. Packaging and professional education should clearly state dose, form, intended population, duration of use, testing considerations, contraindications, and safety limits. Investment in third-party testing, contaminant controls, stability data, accurate potency verification, and transparent sourcing can differentiate products in crowded consumer channels.

Companies should also build partnerships with laboratories, pharmacies, dietitians, nephrologists, endocrinologists, pediatricians, obstetric care providers, and geriatric care networks to support appropriate use. Growth strategies should localize dosage forms, price points, pack sizes, labeling, and education by region while avoiding exaggerated claims related to immunity, cardiovascular outcomes, cancer, or chronic disease prevention unless supported by regulatory-grade evidence.

Research Methodology

This executive summary is grounded in triangulated secondary research from recognized public-health and clinical sources, including national nutrient reference intake frameworks, regulatory guidance, peer-reviewed literature on vitamin D status, and established evidence on deficiency treatment and safety. Market interpretation considers formulation type, therapeutic setting, distribution channel, patient risk group, regional healthcare infrastructure, fortification policy, and testing access.

The analysis prioritizes verified clinical facts over speculative claims. Insights were developed by comparing guideline positions, epidemiological patterns, demographic trends, dietary practices, fortification approaches, laboratory availability, and observed commercialization models across major regions and country clusters. Where evidence remains mixed, the summary distinguishes confirmed deficiency-treatment use from broader wellness or disease-prevention narratives.

Conclusion

Vitamin D therapy remains a resilient healthcare and wellness category because deficiency treatment is clinically established, population risk factors are persistent, and aging demographics continue to elevate bone-health priorities. The strongest commercial opportunities are shifting toward targeted, evidence-based, quality-assured solutions rather than generic high-dose supplementation or unsupported therapeutic positioning.

Manufacturers that combine regulatory compliance, credible science, formulation reliability, safety monitoring, and localized market execution will be best positioned. As AI, diagnostics, and personalized nutrition mature, vitamin D therapy is likely to become more precise, safer, and more integrated into preventive health, deficiency management, renal care, endocrine practice, and chronic-care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vitamin D Therapy Market, by Product Type

  • 7.1. Fortified Food
    • 7.1.1. Beverages
    • 7.1.2. Formulas
  • 7.2. Prescription
  • 7.3. Supplement

8. Vitamin D Therapy Market, by Dosage Form

  • 8.1. Oral
    • 8.1.1. Capsule
    • 8.1.2. Chewable
    • 8.1.3. Liquid
    • 8.1.4. Softgel
    • 8.1.5. Tablet
  • 8.2. Parenteral
  • 8.3. Topical

9. Vitamin D Therapy Market, by Indication

  • 9.1. Hypocalcemia
  • 9.2. Osteoporosis
  • 9.3. Psoriasis
  • 9.4. Rickets

10. Vitamin D Therapy Market, by End User

  • 10.1. Clinics
  • 10.2. Home Healthcare
  • 10.3. Hospitals

11. Vitamin D Therapy Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Vitamin D Therapy Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Vitamin D Therapy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vitamin D Therapy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Alkem Laboratories Ltd.
  • 16.3. Allergan plc
  • 16.4. Amway Corporation
  • 16.5. Aurobindo Pharma Limited
  • 16.6. Bayer AG
  • 16.7. Bio-Techne Corporation
  • 16.8. Cipla Limited
  • 16.9. Dr. Reddy's Laboratories Ltd.
  • 16.10. DSM Nutritional Products AG
  • 16.11. Eli Lilly and Company
  • 16.12. GlaxoSmithKline plc
  • 16.13. Herbalife Nutrition Ltd.
  • 16.14. Lupin Limited
  • 16.15. Merck & Co. Inc.
  • 16.16. Nestle Health Science
  • 16.17. Novartis AG
  • 16.18. Pfizer Inc.
  • 16.19. Roche Holding AG
  • 16.20. Sanofi SA
  • 16.21. Sun Pharmaceutical Industries Ltd.
  • 16.22. Teva Pharmaceutical Industries Ltd.
  • 16.23. Torrent Pharmaceuticals Ltd.
  • 16.24. Zydus Cadila

LIST OF FIGURES

  • FIGURE 1. GLOBAL VITAMIN D THERAPY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VITAMIN D THERAPY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VITAMIN D THERAPY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VITAMIN D THERAPY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VITAMIN D THERAPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VITAMIN D THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FORTIFIED FOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FORTIFIED FOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FORTIFIED FOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BEVERAGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BEVERAGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BEVERAGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FORMULAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FORMULAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FORMULAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PRESCRIPTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PRESCRIPTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PRESCRIPTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUPPLEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SUPPLEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUPPLEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CAPSULE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CAPSULE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CAPSULE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHEWABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHEWABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHEWABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIQUID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SOFTGEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SOFTGEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOFTGEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TABLET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TABLET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TABLET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HYPOCALCEMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HYPOCALCEMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HYPOCALCEMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL OSTEOPOROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL OSTEOPOROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OSTEOPOROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PSORIASIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PSORIASIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PSORIASIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RICKETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RICKETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RICKETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 134. GCC VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 135. GCC VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GCC VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 158. G7 VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 159. G7 VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 161. G7 VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. NATO VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 166. NATO VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 167. NATO VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 168. NATO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NATO VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL VITAMIN D THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CANADA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CANADA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CANADA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 183. CANADA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 184. CANADA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 185. CANADA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. CANADA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CANADA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MEXICO VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. MEXICO VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MEXICO VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 191. MEXICO VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 192. MEXICO VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 193. MEXICO VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 194. MEXICO VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. MEXICO VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. BRAZIL VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 199. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 200. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 201. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. BRAZIL VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. GERMANY VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. GERMANY VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GERMANY VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 215. GERMANY VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 216. GERMANY VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 217. GERMANY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 218. GERMANY VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GERMANY VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. FRANCE VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. FRANCE VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. FRANCE VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 223. FRANCE VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 224. FRANCE VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 225. FRANCE VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 226. FRANCE VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. FRANCE VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. RUSSIA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 231. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 232. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 233. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 234. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. RUSSIA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. ITALY VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. ITALY VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. ITALY VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 239. ITALY VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 240. ITALY VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 241. ITALY VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ITALY VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. ITALY VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. SPAIN VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. SPAIN VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. SPAIN VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 247. SPAIN VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 248. SPAIN VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 249. SPAIN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 250. SPAIN VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. SPAIN VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. INDIA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. INDIA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 263. INDIA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 264. INDIA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 265. INDIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. INDIA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. JAPAN VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. JAPAN VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. JAPAN VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 271. JAPAN VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 272. JAPAN VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. JAPAN VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 279. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 280. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 281. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 282. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. AUSTRALIA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 284. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY FORTIFIED FOOD, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 288. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 289. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. SOUTH KOREA VITAMIN D THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)